In our previous studies, we have shown that adoptively transferred antigen-specific CD8+ CTL clones are detectable post-infusion, persist in the presence of IL-2 supplementation, are able to traffic to tumor sites, and effect anti-tumor responses[1]. This evidence concerns the gene IL2 and neoplasm.